Corrigendum to "IMM-H004 protects against oxygen-glucose deprivation/reperfusion injury to BV2 microglia partly by modulating CKLF1 involved in microglia polarization" [Int. Immunopharmacol. 70 (2019) 69-79].

MLA

Chen, Chen, et al. “Corrigendum to ‘IMM-H004 Protects against Oxygen-Glucose Deprivation/Reperfusion Injury to BV2 Microglia Partly by Modulating CKLF1 Involved in Microglia Polarization’ [Int. Immunopharmacol. 70 (2019) 69-79].” International Immunopharmacology, vol. 133, May 2024, p. 112154. EBSCOhost, https://doi.org/10.1016/j.intimp.2024.112154.

APA

Chen, C., Ai, Q.-D., Chu, S.-F., Zhang, Z., Zhou, X., Luo, P., Liu, Y.-J., & Chen, N.-H. (2024). Corrigendum to “IMM-H004 protects against oxygen-glucose deprivation/reperfusion injury to BV2 microglia partly by modulating CKLF1 involved in microglia polarization” [Int. Immunopharmacol. 70 (2019) 69-79]. International Immunopharmacology, 133, 112154. https://doi.org/10.1016/j.intimp.2024.112154

Chicago

Chen, Chen, Qi-Di Ai, Shi-Feng Chu, Zhao Zhang, Xin Zhou, Piao Luo, Ying-Jiao Liu, and Nai-Hong Chen. 2024. “Corrigendum to ‘IMM-H004 Protects against Oxygen-Glucose Deprivation/Reperfusion Injury to BV2 Microglia Partly by Modulating CKLF1 Involved in Microglia Polarization’ [Int. Immunopharmacol. 70 (2019) 69-79].” International Immunopharmacology 133 (May): 112154. doi:10.1016/j.intimp.2024.112154.